AGRX News and Press, Agile Therapeutics Inc. From 09/09/19

Back in May, Agile Therapeutics ( AGRX ), publicized that they resubmitted Twirla’s NDA to FDA. Twirla is Agile’s lead product candidate that is a low-dose combination hormonal contraceptive patch. Subsequently, Agile stated that the FDA accepted the NDA resubmission with t...

PRINCETON, N.J., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that the underwriters of its previously announced public offering of common stock have exercised in full their option to purchase an additional 1,...

Glu Mobile (NASDAQ: GLUU )  -29%  on Q2 earnings . More news on: Glu Mobile Inc., Obalon Therapeutics, Inc., Workhorse Group Inc., Stocks on the move, Read more ...

PRINCETON, N.J., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of 12,631,579 shares of its common stock at a public offering price of $0.95 per share. The gross ...

PRINCETON, N.J., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All shares being offered are to be sold by Agile ...

Agile Therapeutics (NASDAQ: AGRX ): Q2 GAAP EPS of -$0.08 beats by $0.04 . More news on: Agile Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

FDA Assigned PDUFA (Prescription Drug User Fee Act) Goal Date is November 16, 2019 Cash Expected to Enable Company to Fund Operations through the End of 2019 PRINCETON, N.J., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare compan...

Agile Therapeutics ( AGRX +0.8% ) announced the appointment of Dennis P. Reilly as Chief Financial Officer effective August 5, 2019. More news on: Agile Therapeutics, Inc., Read more ...

Dennis P. Reilly to bring commercial experience to management team Appointment Effective August 5, 2019 PRINCETON, N.J., July 18, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Dennis P. Reil...

Back in May, Agile Therapeutics ( AGRX ), revealed that they resubmitted their NDA for its primary product candidate, Twirla, a low-dose combination hormonal contraceptive patch. Shortly after, Agile announced that the FDA accepted Twirla's NDA resubmission with the PDUFA date set for No...